Amgen

Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Motley Fool
Sun, 02/21/16 - 11:37 am
Gilead Sciences
Amgen
Amgen launches Kyprolis in the UK for multiple myeloma
BioPharma Dive
Thu, 02/18/16 - 05:48 pm
Amgen
Kyprolis
UK
Multiple Myeloma
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Wed, 02/17/16 - 11:33 am
Sandoz
FDA
BPCIA
Amgen
Zarxio
Neupogen
Amgen Ahead of Regeneron; Controlling 60% of PCSK-9 Market
Bidness, ETC
Wed, 02/17/16 - 10:46 am
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
Repatha
Praluent
Amgen blood cell disorder drug meets primary goal in phase 3 trial
Yahoo/Reuters
Tue, 02/16/16 - 10:01 am
Amgen
Aranesp
MDS
clinical trials
Express Scripts sees slow 2016 sales for new cholesterol drugs
Yahoo/Reuters
Fri, 02/12/16 - 04:15 pm
Express Scripts
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
PCSK9 inhibitors
heart failure
Praluent
Repatha
Novartis
Amgen
Sanofi
Regeneron
Amgen Is Now Strides Ahead of Regeneron in the PCSK9 Race
Bidness, ETC
Tue, 02/9/16 - 04:26 pm
Amgen
Regeneron
PCSK9 inhibitors
Praluent
Repatha
Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?
Bidness, ETC
Mon, 02/8/16 - 11:01 am
AbbVie
Amgen
JNJ
anti-TNF
Remicade
Pharmaceuticals Turn To Politics To Protect Prices
Yahoo/Benzinga
Mon, 02/8/16 - 10:20 am
drug pricing
Amgen
Pfizer
2016 Presidential election
How Amgen may Impact Regeneron Q4 Earnings
Bidness, ETC
Thu, 02/4/16 - 06:33 pm
Amgen
Regeneron
earnings
Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen
Fierce Biotech
Fri, 01/29/16 - 08:27 pm
Genentech
asthma
COPD
IL-33
Amgen
Amgen's Q4 Crushed Estimates and Answered 3 Important Questions in the Process
Motley Fool
Fri, 01/29/16 - 10:26 am
Amgen
earnings
3 Key Numbers to Monitor When Amgen Reports Fourth-Quarter Results
Motley Fool
Wed, 01/27/16 - 10:19 am
Amgen
earnings
Sanofi and Regeneron likely to cough up royalties to end Amgen's PCSK9 patent suit: Analyst
Fierce Pharma
Tue, 01/26/16 - 09:03 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Repatha
Praluent
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Fierce Pharma
Tue, 01/26/16 - 09:01 pm
Amgen
biosimilars
Humira
FDA
AbbVie
FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Yahoo
Mon, 01/25/16 - 10:22 pm
FDA
Amgen
biosimilars
biologics
ABP 501
Humira
U.S. top court rules for Amgen over employee lawsuit
Yahoo/Reuters
Mon, 01/25/16 - 10:09 am
Amgen
employee lawsuits
Big Earnings Expectations For Big Biotech
Yahoo/Benzinga
Sun, 01/24/16 - 09:12 pm
earnings
Amgen
Biogen
Celgene
What You Missed at the 2016 J.P. Morgan Healthcare Conference
Motley Fool
Sun, 01/24/16 - 12:25 pm
JPMHC 2016
Amgen
Biogen
Celgene

Pages